Evidence map›Paper›PMID 36843485›Full record

SynthesisEpidemiology and infection2023

Usefulness of linked data for infectious disease events: a systematic review.

Emma Field, Melanie Strathearn, Christopher Boyd-Skinner, Amalie Dyda

Abstract readSystematic Review
In one paragraph

Synthesis in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emma FieldNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.ORCID 0000-0002-5844-3627
Melanie StrathearnSchool of Population Health, University of Queensland, Brisbane, Australia.
Christopher Boyd-SkinnerAustralian Commission on Safety and Quality in Health Care, Sydney, Australia.
Amalie DydaSchool of Population Health, University of Queensland, Brisbane, Australia.ORCID 0000-0003-2806-4834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surveillance is a key public health function to enable early detection of infectious disease events and inform public health action. Data linkage may improve the depth of data for response to infectious disease events. This study aimed to describe the uses of linked data for infectious disease events. A systematic review was conducted using Pubmed, CINAHL and Web of Science. Studies were included if they used data linkage for an acute infectious disease event (e.g. outbreak of disease). We summarised the event, study aims and designs; data sets; linkage methods; outcomes reported; and benefits and limitations. Fifty-four studies were included. Uses of linkage for infectious disease events included assessment of severity of disease and risk factors; improved case finding and contact tracing; and vaccine uptake, safety and effectiveness. The ability to conduct larger scale population level studies was identified as a benefit, in particular for rarer exposures, risk factors or outcomes. Limitations included timeliness, data quality and inability to collect additional variables. This review demonstrated multiple uses of data linkage for infectious disease events. As infectious disease events occur without warning, there is a need to establish pre-approved protocols and the infrastructure for data-linkage to enhance information available during an event.

Indexed as

Communicable DiseasesVaccinesDisease OutbreaksHumansPublic HealthSemantic WebVaccinesEpidemiologyinfectious diseaseinfectious disease epidemiologyoutbreakssurveillance

Identifiers

PMID36843485
PMCPMC10052405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.